A synthetic bivalent ligand of CXCR4 inhibits HIV infection

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 646-650

  Xu, Yan ^a,b   Duggineni, Srinivas ^a   Espitia, Stephen ^c   Richman, Douglas D ^c   An, Jing ^a   Huang, Ziwei ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b JILIN UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bivalent ligand; Cell migration; Chemokine receptors; CXCR4; HIV infection; Peptide antagonist; Protein protein interaction; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CHEMOKINE RECEPTOR CXCR4 MONOCLONAL ANTIBODY; DEXTRO AMINO ACID; DIMER; DV1 PEPTIDE; MONOCLONAL ANTIBODY; PEPTIDE; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; PRIORITY JOURNAL;

HIV; HIV INFECTIONS; HUMANS; PEPTIDES; RECEPTORS, CXCR4; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878992502     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.038     Document Type: Article

References (13)

1. Wu B., Chien E.Y., Mol C.D., Fenalti G., Liu W., Katritch V., Abagyan R., Brooun A., Wells P., Bi F.C., Hamel D.J., Kuhn P., Handel T.M., Cherezov V., Stevens R.C. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 2010, 330:1066-1071.
2. Choi W.T., Kumar S., Madani N., Han X., Tian S., Dong C.Z., Liu D., Duggineni S., Yuan J., Sodroski J.G., Huang Z., An J. A novel synthetic bivalent ligand to probe chemokine receptor CXCR4 dimerization and inhibit HIV-1 entry. Biochemistry 2012, 51:7078-7086.
3. Lane J.R., Sexton P.M., Christopoulos A. Bridging the gap: bitopic ligands of G-protein-coupled receptors. Trends Pharmacol. Sci. 2013, 34:59-66.
4. Harrison C. G protein-coupled receptors: insights into chemokine receptors. Nat. Rev. Drug Discov. 2010, 9:920.
5. Choi W.T., Duggineni S., Xu Y., Huang Z., An J. Drug discovery research targeting the CXC chemokine receptor 4. J. Med. Chem. 2012, 55:977-994.
6. Pease J., Horuk R. Chemokine receptor antagonists. J. Med. Chem. 2012, 55:9363-9392.
7. Zhou N., Luo Z., Luo J., Hall J.W., Huang Z. A novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-II. Biochemistry 2000, 39:3782-3787.
8. Mason J.S., Bortolato A., Congreve M., Marshall F.H. New insights from structural biology into the druggability of G protein-coupled receptors. Trends Pharmacol. Sci. 2012, 33:249-260.
9. Vila-Coro A.J., Rodriguez-Frade J.M., Martin De Ana A., Moreno-Ortiz M.C., Martinez A.C., Mellado M. The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999, 13:1699-1710.
10. Tanaka T., Nomura W., Narumi T., Masuda A., Tamamura H. Bivalent ligands of CXCR4 with rigid linkers for elucidation of the dimerization state in cells. J. Am. Chem. Soc. 2010, 132:15899-15901.
11. Birnkammer T., Spickenreither A., Brunskole I., Lopuch M., Kagermeier N., Bernhardt G., Dove S., Seifert R., Elz S., Buschauer A. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H(2) receptor agonists. J. Med. Chem. 2012, 55:1147-1160.
12. Zhou N., Luo Z., Luo J., Fan X., Cayabyab M., Hiraoka M., Liu D., Han X., Pesavento J., Dong C.Z., Wang Y., An J., Kaji H., Sodroski J.G., Huang Z. Exploring the stereochemistry of CXCR4-peptide recognition and inhibiting HIV-1 entry with D-peptides derived from chemokines. J. Biol. Chem. 2002, 277:17476-17485.
13. Duggineni S., Mitra S., Lamberto I., Han X., Xu Y., An J., Pasquale E.B., Huang Z. Design and synthesis of potent bivalent peptide agonists targeting the EphA2 receptor. ACS Med. Chem. Lett. 2013, 4:344-348.